Related Experiment Videos
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis
A Festa1, R D'Agostino, G Howard
1Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, Texas 78228-3900, USA.
Background:
Microalbuminuria is a risk factor for cardiovascular disease, but the underlying pathomechanisms are still poorly understood. A relationship between C-reactive protein (CRP), a sensitive marker of inflammation, and atherosclerotic disease has been reported recently.
Methods:
We hypothesized that microalbuminuria might be associated with chronic inflammation and investigated the relationship of urinary albumin excretion, as assessed from the albumin-to-creatinine ratio (ACR), in an untimed morning urine specimen, and two inflammatory markers (CRP and fibrinogen) in the large, triethnic population of the Insulin Resistance Atherosclerosis Study (IRAS). After exclusion of subjects with macroalbuminuria, 1481 subjects were studied.
Results:
Both inflammatory markers were related to urinary ACR (r = 0.17 for CRP and r = 0.14 for fibrinogen, both P = 0.0001), an association that remained significant after adjustment for demographic variables, diabetic status, smoking, and use of angiotensin-converting enzyme inhibitors (P < 0.01). Mean levels of CRP and fibrinogen were elevated in microalbuminuric (N = 262) versus normoalbuminuric (N = 1219) subjects (5.37 +/- 0.47 vs. 3.80 +/- 0.15 mg/L and 295.7 +/- 4. 0 vs. 278.2 +/- 1.6 mg/dL, both P < 0.0001). The associations were consistent among nondiabetic and type 2 diabetic subjects and among the three ethnic groups of the IRAS (non-Hispanic whites, blacks, Hispanics). In a logistic regression model, fibrinogen was independently associated with microalbuminuria (P = 0.047), along with hypertension, female gender, waist circumference, and fasting blood glucose, while CRP was not independently related to microalbuminuria in this model (P = 0.26).
Conclusion:
We have shown an association of CRP and fibrinogen with urinary albumin excretion in the microalbuminuric range in type 2 diabetic and nondiabetic individuals. Chronic inflammation therefore emerges as a potential mediator between microalbuminuria and macrovascular disease.
Insights
Microalbuminuria is linked to chronic inflammation, with elevated C-reactive protein (CRP) and fibrinogen levels found in individuals with higher urinary albumin excretion. This suggests inflammation may mediate the link between microalbuminuria and cardiovascular disease.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Inflammation Research
Background:
- Microalbuminuria is a known cardiovascular disease risk factor, but its underlying mechanisms remain unclear.
- C-reactive protein (CRP) is a marker of inflammation associated with atherosclerosis.
Purpose of the Study:
- To investigate the association between microalbuminuria and markers of chronic inflammation, specifically CRP and fibrinogen.
- To explore these relationships within the Insulin Resistance Atherosclerosis Study (IRAS) population.
Main Methods:
- Assessed urinary albumin excretion using the albumin-to-creatinine ratio (ACR) in morning urine samples.
- Measured levels of CRP and fibrinogen in 1481 subjects from the IRAS study, excluding those with macroalbuminuria.
Main Results:
- Both CRP and fibrinogen showed a significant association with urinary ACR, even after adjusting for confounding factors.
- Microalbuminuric subjects had significantly higher mean levels of CRP and fibrinogen compared to normoalbuminuric subjects.
- Fibrinogen, but not CRP, was independently associated with microalbuminuria in a logistic regression model, alongside hypertension, gender, waist circumference, and glucose levels.
Conclusions:
- CRP and fibrinogen are associated with urinary albumin excretion in individuals with microalbuminuria, including those with and without type 2 diabetes.
- Chronic inflammation is identified as a potential mediator linking microalbuminuria to macrovascular complications.
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational